NO20076283L - Fremgangsmate for produksjon av lavmolekylaer vektheparin - Google Patents

Fremgangsmate for produksjon av lavmolekylaer vektheparin

Info

Publication number
NO20076283L
NO20076283L NO20076283A NO20076283A NO20076283L NO 20076283 L NO20076283 L NO 20076283L NO 20076283 A NO20076283 A NO 20076283A NO 20076283 A NO20076283 A NO 20076283A NO 20076283 L NO20076283 L NO 20076283L
Authority
NO
Norway
Prior art keywords
molecular weight
heparin
low molecular
production
weight heparin
Prior art date
Application number
NO20076283A
Other languages
English (en)
Norwegian (no)
Inventor
Ragnar Flengsrud
Ole Rasmus Odegaard
Original Assignee
Uni For Miljo Og Biovitenskap
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni For Miljo Og Biovitenskap filed Critical Uni For Miljo Og Biovitenskap
Publication of NO20076283L publication Critical patent/NO20076283L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/28—Substances of animal origin, e.g. gelatin or collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20076283A 2005-05-09 2007-12-06 Fremgangsmate for produksjon av lavmolekylaer vektheparin NO20076283L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0509433.9A GB0509433D0 (en) 2005-05-09 2005-05-09 Method
PCT/GB2006/001690 WO2006120425A1 (fr) 2005-05-09 2006-05-09 Procede de production d'heparine a faible masse moleculaire

Publications (1)

Publication Number Publication Date
NO20076283L true NO20076283L (no) 2008-02-06

Family

ID=34685309

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076283A NO20076283L (no) 2005-05-09 2007-12-06 Fremgangsmate for produksjon av lavmolekylaer vektheparin

Country Status (10)

Country Link
US (1) US20090105194A1 (fr)
EP (1) EP1899384A1 (fr)
JP (1) JP2008543987A (fr)
CN (1) CN101218259B (fr)
AU (1) AU2006245577A1 (fr)
CA (1) CA2608136A1 (fr)
GB (1) GB0509433D0 (fr)
NO (1) NO20076283L (fr)
NZ (1) NZ563821A (fr)
WO (1) WO2006120425A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9173989B2 (en) 2005-12-13 2015-11-03 Exthera Medical Corporation Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
AU2008265838A1 (en) * 2007-06-18 2008-12-24 Exthera Medical Llc Device and method for restoration of the condition of blood
WO2008155683A1 (fr) 2007-06-18 2008-12-24 Firmenich Sa Compositions agissant contre les mauvaises odeurs et leur procédé d'utilisation
GB0812919D0 (en) * 2008-07-15 2008-08-20 Norwegian University Of Life Sciences Process
WO2011068897A1 (fr) 2009-12-01 2011-06-09 Exthera Medical, Llc Procédé d'élimination de cytokines du sang par des polysaccharides immobilisés en surface
WO2012112724A1 (fr) 2011-02-15 2012-08-23 Exthera Medical, Llc Dispositifs et procédé d'élimination de toxines, de cytokines inflammatoires et de pathogènes à diffusion hématogène
DK2861273T3 (da) 2012-06-13 2017-11-27 Exthera Medical Corp Anvendelse af heparin og kulhydrater til behandling af cancer.
JP6648009B2 (ja) 2013-06-24 2020-02-14 エクステラ・メディカル・コーポレーション マンノース被覆基材を含有する血液濾過システム
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
BR112016024569B1 (pt) 2014-04-24 2023-01-03 Exthera Medical Corporation Método ex vivo para remover bactérias de uma amostra retirada de um indivíduo que é suspeito de estar infectado com a mesma
BR112017004059A2 (pt) 2014-09-22 2017-12-05 Exthera Medical Corp dispositivo de hemoperfusão utilizável
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
CN108179162A (zh) * 2018-01-16 2018-06-19 浙江海洋大学 一种低分子量肝素的制备方法
WO2020013346A1 (fr) 2018-07-11 2020-01-16 Ajinomoto Co., Inc. Procédé pour la sulfurylation enzymatique d'alcools et d'amines utilisant une bactérie de la famille des enterobacteriaceae
PE20212330A1 (es) 2019-04-26 2021-12-14 Farm Rovi Lab Sa Procedimiento de obtencion de heparinas de bajo peso molecular por filtracion de flujo tangencial

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533549A (en) * 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
IT1230582B (it) * 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
CN1284510A (zh) * 1999-08-17 2001-02-21 孙润伟 利用猪、牛、羊肺沉淀法生产肝素钠
WO2002076475A2 (fr) * 2001-03-23 2002-10-03 Bioparken As Anticoagulant
EP1524276A1 (fr) * 2003-10-16 2005-04-20 Laboratori Derivati Organici S.P.A. Procédé à étapes multiples pour la dépolymérisation de héparine et produits ainsi obtenus

Also Published As

Publication number Publication date
CN101218259A (zh) 2008-07-09
GB0509433D0 (en) 2005-06-15
EP1899384A1 (fr) 2008-03-19
WO2006120425A1 (fr) 2006-11-16
CA2608136A1 (fr) 2006-11-16
JP2008543987A (ja) 2008-12-04
CN101218259B (zh) 2011-06-15
US20090105194A1 (en) 2009-04-23
NZ563821A (en) 2010-09-30
AU2006245577A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
NO20076283L (no) Fremgangsmate for produksjon av lavmolekylaer vektheparin
AR059173A1 (es) Procedimiento para la obtencion de un etanol pobre en agua por deshidratacion con membranas y su empleo como educto en la elaboracion de etbe.
TW200621690A (en) Novel compounds
WO2010147686A3 (fr) Procédés de purification de petites protéines immunopharmaceutiques modulaires
NO20083057L (no) Sulfonyl substituerte 1H-indoler som ligander til 5-hydroksytryptamin reseptorer
DK1888541T3 (da) Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander
DE602007009995D1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
WO2007113327A3 (fr) Dérivés de n-cyclopropylsulfonylamide fongicides
DE602007003197D1 (de) Verfahren zur herstellung von morphinan-6-on-produkten mit geringen konzentrationen von alpha-, beta-ungesättigten ketonverbindungen
NO20100062L (no) Overflatereagert kalsiumkarbonat i kombinasjon med hydrofob adsorbent for vannbehandling
DE602007005024D1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
DE602006004160D1 (de) Niedertemperatur-Trocknungsverfahren zur Herstellung von arzneimittelhaltigen Polymerzusammensetzungen
TW200505837A (en) Novel compounds
WO2006009836A3 (fr) Composes associes au facteur de differenciation tissulaire et leurs analogues
MX2010007443A (es) Metodo para tratar anemias de respuesta baja a eritropoyetina.
WO2007052023A3 (fr) Composes
NO20085417L (no) Krystallinske former av 11beta-(4-acetylfenyl)-20,20,21,21,21-pentafluor-17-hydroksy-19-nor-17alfa-pregna-4,9-dien-3-on
DE502006007666D1 (de) Erialien
EA201001044A1 (ru) Умами-активная фракция и способ её приготовления
WO2008005908A3 (fr) Dérivés de pyridoïmidazole
NO20091108L (no) Fremgangsmate for fjerning av jodidforbindelse fra organisk syre
WO2010028338A3 (fr) Nouveaux composés comme ligands de récepteurs de cannabinoïdes
WO2010054024A3 (fr) Nouveaux composés en tant que ligands des récepteurs cannabinoïdes
NO20091986L (no) Tykningsmiddelblanding
WO2007035872A3 (fr) Composés apparentés au fdt et leurs analogues

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application